NPS MedicineWise Revenue and Competitors

Darlinghurst, AU

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • NPS MedicineWise's estimated annual revenue is currently $60.6M per year.(i)
  • NPS MedicineWise's estimated revenue per employee is $297,000

Employee Data

  • NPS MedicineWise has 204 Employees.(i)
  • NPS MedicineWise grew their employee count by -18% last year.

NPS MedicineWise's People

NameTitleEmail/Phone
1
Senior Clinical Program OfficerReveal Email/Phone
2
Medical Content and Education ManagerReveal Email/Phone
3
Design and Innovation ManagerReveal Email/Phone
4
National Manager, Service Delivery & PHN EngagementReveal Email/Phone
5
Strategic Partnerships ManagerReveal Email/Phone
6
Program ManagerReveal Email/Phone
7
Stakeholder Relations and Policy ManagerReveal Email/Phone
8
Manager, Programs and Clinical ServicesReveal Email/Phone
9
Executive ManagerReveal Email/Phone
10
Product Portfolio Manager, Health Informatics and Decision SupportReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.5M30N/AN/AN/A
#2
$36.2M1341%N/AN/A
#3
$59.4M20023%N/AN/A
#4
$28.4M1052%N/AN/A
#5
$29.7M1106%N/AN/A
#6
$20.8M770%N/AN/A
#7
$17M708%N/AN/A
#8
$65.3M2204%N/AN/A
#9
$24.8M922%N/AN/A
#10
$48.4M163-1%N/AN/A
Add Company

What Is NPS MedicineWise?

NPS MedicineWise helps people to make better decisions about medicines and medical tests, leading to better health outcomes. We enable health professionals to keep up to date with the latest evidence and provide individuals with the tools and knowledge to make better decisions. Globally recognised for our work in quality use of medicines, we believe individuals are gatekeepers of their health decisions. Everyone is entitled to impartial information that enables them to navigate their choices and get the most from their health professionals. We are for a medicinewise Australia. We want best practice decision-making to be well understood, embedded in health systems and put into action every day. We want all Australians to be medicinewise and experience the health and economic benefits this brings. NPS Medicinewise information, resources and tools are evidence-based and impartial and developed in conjunction with expert advisory groups and our extensive networks across the health sector. We also publish the journal Australian Prescriber an independent review of medicines & therapeutics. We are funded by the Australian Government Department of Health. Health information & medical writing, Quality Use of Medicines, eHealth, Health Professional activities

keywords:N/A

N/A

Total Funding

204

Number of Employees

$60.6M

Revenue (est)

-18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

NPS MedicineWise News

2022-04-17 - Global Sulfasalazine Market 2022 Sales Revenue – Crescent ...

Crescent Pharma Limited; Pfizer; Saaz-DS; KRKA; Vintage; Qualitest; NPS Medicinewise; Kamp Medicine; Hubei Wudang; Hebei Yinengpu...

2022-04-13 - Empagliflozin for heart failure with reduced ejection fraction

See NPS MedicineWise RADAR article Dapagliflozin (Forxiga) for heart failure with reduced ejection fraction (LVEF ? 40%) 'What is it?' section...

2022-03-30 - Treatment options for severe asthma expanding on the PBS ...

This resource was developed by NPS MedicineWise for health professionals. 2021 GINA global strategy. In 2021, GINA (Global Initiative for Asthma)...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M2142%N/A
#2
$39.1M218-13%N/A
#3
$25.8M2306%N/A
#4
$65.7M238N/AN/A
#5
$34.7M26334%N/A